اعلان هااااااااااااااام


Translate

Research and Markets: Blood Cancer - Pipeline Review, H2 2012 Report Features Players such as Boehringer Ingelheim GmbH and Amgen Inc.

Friday, January 18, 2013

WN.com - Health News
Latest headlines from WN Network
Research and Markets: Blood Cancer - Pipeline Review, H2 2012 Report Features Players such as Boehringer Ingelheim GmbH and Amgen Inc.
Jan 18th 2013, 10:06

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/mkxrqf/blood_cancer) has announced the addition of Global Markets Direct's new report "Blood Cancer - Pipeline Review, H2 2012" to their offering. “Blood Cancer - Pipeline Review, H2 2012” Global Markets Direct's, 'Blood Cancer - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Blood Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Blood Cancer. Blood Cancer -...
You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

0 Responses to Research and Markets: Blood Cancer - Pipeline Review, H2 2012 Report Features Players such as Boehringer Ingelheim GmbH and Amgen Inc.

Post a Comment